On June 2, the medical net was less than 80 percent of Chinese medicine, but it produced more than 90 percent of the drug. How to solve this puzzle? 

 

"In 2013 ~ 2016 national monitoring drug quality to sample showed that Chinese herbal medicine and yinpian overall qualified rate of 64%, 68%, 75% and 77% respectively, the qualification rate of increase year by year, steadily to the good trend. But compared with other drugs, Chinese herbal medicine and yinpian fraction defective is still high." Ma shuang, director of the China food and drug testing institute (hereinafter referred to as the "middle school"), was the first financial statement. 

 

The quality problem of Chinese medicine is long-standing, but in its back end, the quality of Chinese medicine is much better than that of Chinese medicine. In court, according to data in the 2015 national assessment to sample, 43 varieties according to the current drug standards and test methods and test item 5669 batch inspection, unqualified batch 146, qualified rate is as high as 97.42%. 

 

The national food administration of drug safety has released the 2016 annual drug inspection report confirmed that the problems of traditional Chinese medicine yinpian, food drug administration of drug safety, supervision department jian-hua ding, according to a report conference 2016 withdrew 172 GMP pharmaceutical production quality management standard certificate. Of these, 81 were involved in Chinese medicine, accounting for 47.6 percent. The traditional logic of the cold and the undead seems to have touched the wall here. 

 

In fact, unqualified Chinese medicine, 100 percent of the production doesn't come out of the qualified drug. "If a lot of Chinese medicine fails to qualify, it will exacerbate the risk of substandard drugs." "Said one national pharmacopeia expert. 

 

The rate of high disqualification of Chinese medicine 

 

Development of traditional Chinese medicine in the "healthy China" occupies an important place in the big national policy, the policy of the state shall encourage the development of the industry of traditional Chinese medicine has been introduced, has brought the industry rapid development opportunities. 

 

The health care policy offers many positive policies for hospitals to use Chinese medicine. , for example, Chinese medicine yinpian don't cancel the hospital bonus, not to participate in provincial unified bidding, do not calculate hospital medicine proportion, temporarily not perform two votes, into the pharmacopoeia of the Chinese medicine yinpian include all essential drugs and medical insurance directory, the new health care continue to Chinese medicine yinpian use exclude directory (part of your fine herbs) to submit an expense account management. In addition, foreign investment has been banned into the Chinese medicine and beverage industry (TCM). In the future, the regulations on the protection of traditional Chinese medicines are expected to be included in the protection regulations of traditional Chinese medicines, such as the endangered species of technology, the variety of toxic concoctions, the technological innovation and the feature films. 

 

"Under the national policy, Chinese medicine yinpian 12.45% year-on-year growth rate higher than that of chemical medicines, proprietary Chinese medicine, but also to see at the same time, Chinese medicine yinpian profit margins in the industry is the lowest, only single-digit profit margins, 6.96%. The main cause is the production of yinpian enterprise scale is generally small, fixed assets investment relative finished products smaller, in addition the sham as the genuine, the industry as a whole slices vicious competition." "Says a medical industry expert. 

 

At the same time of development, because of Chinese medicine yinpian long industrial chain, across multiple industries, involving several regulators, industry regulation is difficult, and quality problems. 

 

The state administration of food and drug administration has been without a halt to the problems of Chinese medicine. Continuous released since 2016, administration of traditional Chinese medicine yinpian market sampling observation unqualified notice, a total of five period, involving 184 suppliers or production companies, 16 herbs/slices varieties, unqualified batch of 286, the main problem is character, identification, content determination and sulfur dioxide residue does not comply with the pharmacopoeia standards, at the same time some problems such as dyeing, weight gain, the adulteration. 

 

 

 

According to ma, the problems are mainly fake and inferior. The use of organic dyes to dye bad medicines; To be motivated by interest; The problem of oversmoking; The storage of substandard products can cause worm and mould problems. Farming practices don't lead to quality problems. 

 

"Due to the toxicity of organic dyes are larger, and even have carcinogenic, teratogenic effects, so the medicine dyeing behavior is not only a fraud behavior, at the same time also increased security risks, must crack down on. In the industry with sulphur fumigation medicine, how to protect wet weight, improve the appearance and increase the presentation, etc. Studies have shown that large and widespread use of sulfur fumigation, will not only affect the quality of the medicinal herbs and yinpian, will cause harm to human body health." The horse doubles as a sign. 

 

"Chinese medicine yinpian quality problems, after all belong to the agricultural and sideline products, starting from the cultivation link, in order to increase production, heavy use of chemical fertilizers and pesticides, ginseng looks like carrots. In the link, the insect, mildew proof, in order to use sulphur fumigation, new storage means the cost is high, a lot of people in order to save cost use sulphur fumigation." Li congyi, general manager of the OTC affairs division of kangmei pharmaceutical co., said in a statement. 

 

In fact, in order to improve Chinese medicine yinpian market, national food drug safety administration of special operation was started in 2013, expose the problems existing in the traditional Chinese medicine, also interviewed the 17 Chinese medicinal materials professional market in cities as the head of the government, and signed with the responsibility of Chinese medicinal materials professional market management. However, substandard Chinese medicine is still there. 

 

"Because of traditional Chinese medicine industry chain not only long and links, and the most front-end ZhongYangShi herbs and medicinal herbs pretreating and storage of origin, Chinese traditional medicine trade is not belongs to the category of drug regulatory, give yinpian quality of raw materials and finished products of drugs increased a lot of difficulty." "The country's pharmacopeia experts said. 

 

According to the field investigation found that Chinese herbal medicine ZhongYangShi and current phase of the main problems are: medicinal material base source is not clear, authentic herbs degradation, pesticide residues and heavy metal residue limit; The pharmaceutical farmers lack the provision of high quality seedlings and scientific breeding and breeding, and the lack of organized large-scale farming; The market is volatile and the market is easily manipulated by speculators. Herbalist pretreating of almost no country of origin and the ability to long-term preservation, fresh medicine can only be selling at a lower price, but not in the realm of regulatory operators generally adopt the adulteration of medicinal materials, weight gain, dyeing techniques and sulphur fumigation to illegal profit. 

 

The threat to Chinese medicine 

 

In addition to the quality problem, there are also problems in the circulation. 

 

"The Chinese herbal medicine circulation more chaos. 17 medicinal materials of Chinese herbal medicine market, and into the traditional enterprise's most, the second is into the hospital, the third is to pharmacy. The unqualified medicinal herbs, one hundred percent don't come out qualified proprietary Chinese medicine production. But because of traditional quality detection project is just one component, some companies will add more contains the ingredients of medicinal herbs, and other ingredients to reduce, even some enterprises to add chemical composition, under such conditions, detection of proprietary Chinese medicine qualified rate is very high." "Mr. Li said. 

 

In addition to the problem of origin, the current situation of Chinese medicine is not optimistic. According to the expert introduction, and finished drug dealers purchase garment pattern is different, most of the medical institutions and retail pharmacy procurement of slices is directly and factory slices for buying and selling, but in fact, because of geographical restrictions and "hidden rules" the objective, almost no ability to yinpian production enterprises control marketing channel. 

 

Then gave birth to the following two modes: one is the yinpian enterprise only through "medicine worms" without business qualification will sell yinpian provided to the buyer, at the same time slices production enterprises were forcibly occupied most of the profits, resulting in product quality declining, even directly from the no qualification to be purchasing products; Secondly, most of the production enterprises slices are not capable of producing hundreds of slices of gauge, because cannot master the sales channel, so a lot of medicinal materials operators not only on the procurement of medicines checkers, also their illegal processing slices, after purchase sales invoice to formal yinpian production enterprises, to enter legal marketing channels. These patterns seriously threaten the quality of traditional Chinese medicine and make it difficult to produce and sell legitimate products. 

 

"Proprietary Chinese medicine enterprises according to GMP for feeding, or belong to illegal, big business problems, mainly is one of the few enterprises, in order to save costs, will buy some cheap, substandard medicines. Because of the price hike in agricultural and sideline products, they will use inferior raw material feeding." "Said tu pengfei, the director of the national pharmacopoeia commission. 

 

In 2016, the food can be seen in the administration of drug safety flight check, 19 proprietary Chinese medicine production enterprises, has a dozen are not carried out in accordance with the GMP production, traditional Chinese medicine, Chinese medicine yinpian material management confusion. Individual proprietary Chinese medicine production enterprises, in response to the pharmaceutical supervisory and administrative departments at all levels of the supervision and inspection, make warehouse material parameter and in-out warehouse records, according to the traditional Chinese medicinal materials production retracing the usage, dosage and on-demand fabricated material parameter. 

 

"For the unqualified proprietary Chinese medicine, and some can be found out, some look not to come out. Because some proprietary Chinese medicine not to determine the content of some proprietary Chinese medicine composition is not identify objects, also look not to come out. In addition, because the cost is very high, at present most of the traditional enterprise no fingerprint, only Chinese caterpillar fungus and so on some expensive medicinal materials in use." "Said tu pengfei. 

 

According to industry experts, the high quality of Chinese medicine is inconsistent with the high quality of Chinese medicine. Chinese medicine, Chinese medicine and Chinese medicine are an organic whole, with lips and teeth. The quality of Chinese medicine is directly concerned with the effect of traditional Chinese medicine. But Chinese medicine yinpian the regulation of the industry, there have been many department management, certainly will extend to ZhongYangShi traditional Chinese medicinal materials and Chinese herbal medicine trade field, only the multi-sectoral cooperation, can change the problems existing in the traditional Chinese medicinal materials quality, and even a threat to Chinese patent medicine.